JNJ Johnson & Johnson
NYSE · SEC CIK 200406 · EDGAR
- Bought, last 12 months
- $257.7K 1 purchases by 1 insiders
- Sold, last 12 months
- $154.85M 16 sales by 10 insiders
- Filings on record
- 335 since 2021-09-09, latest 2026-09-10 20:51
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| Wolk Joseph J | EVP, CFO | — | $21.77M |
| REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| Swanson James D. | EVP, CIO | — | $15.11M |
| Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| Forminard Elizabeth | EVP, CLO | — | $4.09M |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 353
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Wolk Joseph J | EVP, CFO | A - Grant | $0.00 | +20.7K | 59.0K | +54% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $162.01 | -8,578 | 50.4K | -15% | -$1.39M |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | A - Grant | $0.00 | +10.8K | 83.3K | +15% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $162.01 | -4,891 | 78.4K | -6% | -$792.4K |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | A - Grant | $0.00 | +21.4K | 150.2K | +17% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $162.01 | -10.6K | 139.6K | -7% | -$1.71M |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Swanson James D. | See Remarks | A - Grant | $0.00 | +3,228 | 11.2K | +41% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Swanson James D. | See Remarks | F - Tax | $162.01 | -918 | 10.3K | -8% | -$148.7K |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Mongon Thibaut | EVP, WW COB, Cons Health | A - Grant | $0.00 | +13.7K | 72.3K | +23% | $0 |
| D | 2023-02-15 19:25 | 2023-02-13 | JNJ | Mongon Thibaut | EVP, WW COB, Cons Health | F - Tax | $162.01 | -6,430 | 65.9K | -9% | -$1.04M |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | A - Grant | $0.00 | +18.0K | 62.0K | +41% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | F - Tax | $162.01 | -7,158 | 54.8K | -12% | -$1.16M |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Hait William | See Remarks | A - Grant | $0.00 | +9,640 | 92.3K | +12% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Hait William | See Remarks | F - Tax | $162.01 | -4,586 | 87.7K | -5% | -$743.0K |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Fasolo Peter | EVP, Chief HR Off | A - Grant | $0.00 | +12.5K | 128.5K | +11% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $162.01 | -5,765 | 122.7K | -4% | -$934.0K |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Duato Joaquin | CEO, COB, Dir | A - Grant | $0.00 | +31.3K | 330.0K | +10% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $162.01 | -13.6K | 316.4K | -4% | -$2.20M |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Decker Robert J | VP Corp. Ctrl | A - Grant | $0.00 | +1,451 | 17.3K | +9% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Decker Robert J | VP Corp. Ctrl | F - Tax | $162.01 | -397 | 16.9K | -2% | -$64.3K |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Forminard Elizabeth | GC, Executive VP | A - Grant | $0.00 | +2,555 | 6,408 | +66% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Forminard Elizabeth | GC, Executive VP | F - Tax | $162.01 | -924 | 5,484 | -14% | -$149.7K |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | A - Grant | $0.00 | +3,981 | 20.6K | +24% | $0 |
| D | 2023-02-15 19:24 | 2023-02-13 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $162.01 | -1,440 | 19.2K | -7% | -$233.3K |
| D | 2023-02-14 16:37 | 2023-02-10 | JNJ | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +5,220 | 300.9K | +2% | $0 |
| D | 2023-02-14 16:37 | 2023-02-10 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $162.08 | -2,267 | 298.7K | -0.8% | -$367.4K |
| D | 2023-02-14 16:37 | 2023-02-10 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | M - OptEx | $0.00 | +1,807 | 73.1K | +3% | $0 |
| D | 2023-02-14 16:37 | 2023-02-10 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $162.08 | -667 | 72.5K | -0.9% | -$108.1K |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $0.00 | +3,449 | 39.3K | +10% | $0 |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $162.08 | -979 | 38.3K | -2% | -$158.7K |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +3,570 | 130.0K | +3% | $0 |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $162.08 | -1,289 | 128.7K | -1.0% | -$208.9K |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | M - OptEx | $0.00 | +2,999 | 44.8K | +7% | $0 |
| D | 2023-02-14 16:36 | 2023-02-10 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | F - Tax | $162.08 | -823 | 44.0K | -2% | -$133.4K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Forminard Elizabeth | GC, Executive VP | M - OptEx | $0.00 | +1,022 | 4,233 | +32% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Forminard Elizabeth | GC, Executive VP | F - Tax | $162.08 | -380 | 3,853 | -9% | -$61.6K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Hait William | See Remarks | M - OptEx | $0.00 | +3,856 | 84.1K | +5% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Hait William | See Remarks | F - Tax | $162.08 | -1,399 | 82.7K | -2% | -$226.7K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Mongon Thibaut | EVP, WW COB, Cons Health | M - OptEx | $0.00 | +2,285 | 59.5K | +4% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Mongon Thibaut | EVP, WW COB, Cons Health | F - Tax | $162.08 | -826 | 58.6K | -1% | -$133.9K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +581 | 16.1K | +4% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Decker Robert J | VP Corp. Ctrl | F - Tax | $162.08 | -191 | 15.9K | -1% | -$31.0K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +1,592 | 17.3K | +10% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $162.08 | -597 | 16.7K | -3% | -$96.8K |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +2,078 | 116.8K | +2% | $0 |
| D | 2023-02-14 16:35 | 2023-02-10 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $162.08 | -761 | 116.0K | -0.7% | -$123.3K |
| D | 2023-02-14 16:34 | 2023-02-10 | JNJ | Swanson James D. | See Remarks | M - OptEx | $0.00 | +1,291 | 8,355 | +18% | $0 |
| D | 2023-02-14 16:34 | 2023-02-10 | JNJ | Swanson James D. | See Remarks | F - Tax | $162.08 | -388 | 7,967 | -5% | -$62.9K |
| D | 2023-01-18 16:39 | 2023-01-17 | JNJ | Gorsky Alex | Dir | M - OptEx | $72.54 | +547.7K | 1.13M | +94% | +$39.73M |
| D | 2023-01-18 16:39 | 2023-01-17 | JNJ | Gorsky Alex | Dir | F - Tax | $173.43 | -366.6K | 766.6K | -32% | -$63.58M |
| D | 2023-01-18 16:39 | 2023-01-17 | JNJ | Duato Joaquin | CEO, COB, Dir | M - OptEx | $72.54 | +148.5K | 394.5K | +60% | +$10.77M |
| D | 2023-01-18 16:39 | 2023-01-17 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $173.43 | -98.8K | 295.7K | -25% | -$17.13M |
| DM | 2022-12-15 16:34 | 2022-04-20 | JNJ | Wolk Joseph J | EVP, CFO | G - Gift | $0.00 | -46 | 35.8K | -0.1% | $0 |
| DM | 2022-12-15 16:34 | 2022-12-13 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $88.19 | +14.8K | 50.6K | +41% | +$1.30M |
| DM | 2022-12-15 16:34 | 2022-12-13 | JNJ | Wolk Joseph J | EVP, CFO | S - Sale+OE | $179.60 | -14.8K | 35.8K | -29% | -$2.65M |
| D | 2022-12-02 16:32 | 2022-11-30 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | M - OptEx | $72.54 | +73.3K | 115.1K | +175% | +$5.32M |
| DM | 2022-12-02 16:32 | 2022-11-30 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | S - Sale+OE | $175.47 | -73.3K | 41.8K | -64% | -$12.87M |
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $72.54 | +76.9K | 203.4K | +61% | +$5.58M |
| D | 2022-11-23 16:44 | 2022-11-22 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | S - Sale+OE | $176.78 | -76.9K | 126.5K | -38% | -$13.60M |
| D | 2022-11-21 16:33 | 2022-11-18 | JNJ | Decker Robert J | CAO, Ctrl | M - OptEx | $90.44 | +16.9K | 32.4K | +109% | +$1.53M |
| D | 2022-11-21 16:33 | 2022-11-18 | JNJ | Decker Robert J | CAO, Ctrl | S - Sale+OE | $175.00 | -16.9K | 15.5K | -52% | -$2.96M |
| D | 2022-11-10 16:47 | 2022-11-09 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | M - OptEx | $72.54 | +16.4K | 87.7K | +23% | +$1.19M |
| D | 2022-11-10 16:47 | 2022-11-09 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | S - Sale+OE | $173.42 | -16.4K | 71.3K | -19% | -$2.85M |
| DM | 2022-11-09 17:01 | 2022-11-07 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | M - OptEx | $109.99 | +17.0K | 57.2K | +42% | +$1.87M |
| DM | 2022-11-08 16:59 | 2022-11-04 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | M - OptEx | $130.77 | +35.2K | 75.4K | +88% | +$4.61M |
| DM | 2022-11-08 16:59 | 2022-11-04 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | S - Sale+OE | $171.18 | -35.2K | 40.1K | -47% | -$6.03M |
| D | 2022-11-04 16:30 | 2022-11-02 | JNJ | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +9,912 | 11.0K | +914% | $0 |
| D | 2022-11-04 16:30 | 2022-11-02 | JNJ | Swanson James D. | EVP, CIO | F - Tax | $172.29 | -3,932 | 7,064 | -36% | -$677.4K |
| M | 2022-10-26 19:21 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.36 | -29.3K | 114.7K | -20% | -$5.02M |
| M | 2022-10-26 19:21 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.19 | -20.9K | 144.0K | -13% | -$3.57M |
| M | 2022-10-26 19:20 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.22 | -13.0K | 164.8K | -7% | -$2.23M |
| M | 2022-10-26 19:20 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.14 | -8,256 | 179.9K | -4% | -$1.41M |
| M | 2022-10-26 19:20 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $171.13 | -4,263 | 184.9K | -2% | -$729.5K |
| D | 2022-10-26 19:20 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $115.67 | +78.5K | 193.1K | +68% | +$9.08M |
| DM | 2022-10-26 19:20 | 2022-10-24 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale+OE | $171.02 | -2,815 | 189.8K | -1% | -$481.4K |
| D | 2022-10-26 16:51 | 2022-10-24 | JNJ | Hait William | See Remarks | M - OptEx | $90.44 | +15.0K | 95.2K | +19% | +$1.36M |
| DM | 2022-10-26 16:51 | 2022-10-24 | JNJ | Hait William | See Remarks | S - Sale+OE | $171.55 | -15.0K | 80.2K | -16% | -$2.57M |
| M | 2022-10-21 16:31 | 2022-10-19 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $164.50 | -22.9K | 114.7K | -17% | -$3.76M |
| M | 2022-10-21 16:31 | 2022-10-19 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $164.50 | -29.9K | 136.2K | -18% | -$4.93M |
| M | 2022-10-21 16:31 | 2022-10-19 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $164.50 | -13.7K | 167.5K | -8% | -$2.25M |
| D | 2022-10-21 16:31 | 2022-10-19 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $101.87 | +70.1K | 184.8K | +61% | +$7.14M |
| DM | 2022-10-21 16:31 | 2022-10-19 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale+OE | $164.50 | -3,613 | 181.2K | -2% | -$594.3K |
| D | 2022-06-14 18:28 | 2022-06-10 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | M - OptEx | $72.54 | +40.0K | 111.3K | +56% | +$2.90M |
| DM | 2022-06-14 18:28 | 2022-06-10 | JNJ | Wengel Kathryn E | EVP, Chief GSC Off | S - Sale+OE | $173.00 | -40.0K | 71.3K | -36% | -$6.92M |
| D | 2022-05-31 17:21 | 2022-05-26 | JNJ | Decker Robert J | CAO, Ctrl | M - OptEx | $72.54 | +8,462 | 23.9K | +55% | +$613.8K |
| D | 2022-05-31 17:21 | 2022-05-26 | JNJ | Decker Robert J | CAO, Ctrl | S - Sale+OE | $180.00 | -8,462 | 15.5K | -35% | -$1.52M |
| D | 2022-04-25 16:33 | 2022-04-21 | JNJ | Hait William | See Remarks | M - OptEx | $90.44 | +29.7K | 109.9K | +37% | +$2.69M |
| DM | 2022-04-25 16:33 | 2022-04-21 | JNJ | Hait William | See Remarks | S - Sale+OE | $183.58 | -29.7K | 80.2K | -27% | -$5.45M |
| M | 2022-03-21 16:38 | 2022-03-17 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | S - Sale | $176.25 | -23.7K | 40.1K | -37% | -$4.17M |
| DM | 2022-03-21 16:38 | 2022-03-17 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | M - OptEx | $100.69 | +30.8K | 74.7K | +70% | +$3.10M |
| DM | 2022-03-21 16:38 | 2022-03-17 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | S - Sale+OE | $176.26 | -10.9K | 63.8K | -15% | -$1.92M |
| D | 2022-03-17 16:30 | 2022-03-15 | JNJ | Decker Robert J | CAO, Ctrl | M - OptEx | $72.54 | +5,000 | 20.5K | +32% | +$362.7K |
| DM | 2022-03-17 16:30 | 2022-03-15 | JNJ | Decker Robert J | CAO, Ctrl | S - Sale+OE | $175.51 | -5,000 | 15.5K | -24% | -$877.5K |
| D | 2022-02-18 19:15 | 2022-02-15 | JNJ | Hait William | See Remarks | M - OptEx | $0.00 | +8,128 | 84.4K | +11% | $0 |
| D | 2022-02-18 19:15 | 2022-02-15 | JNJ | Hait William | See Remarks | F - Tax | $165.89 | -4,158 | 80.2K | -5% | -$689.8K |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Decker Robert J | CAO, Ctrl | M - OptEx | $0.00 | +903 | 15.7K | +6% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Decker Robert J | CAO, Ctrl | F - Tax | $165.89 | -248 | 15.5K | -2% | -$41.1K |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $0.00 | +18.1K | 135.3K | +15% | $0 |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $165.89 | -8,841 | 126.5K | -7% | -$1.47M |
| D | 2022-02-17 06:01 | 2022-02-15 | JNJ | Mongon Thibaut | EVP, WW COB, Consumer | M - OptEx | $0.00 | +3,922 | 45.7K | +9% | $0 |
Purchase Sale Sale after option exercise All abbreviations